Journal of Neuroimmune Pharmacology

, Volume 7, Issue 4, pp 731–739 | Cite as

Interplay Between Wnt/β-Catenin Signaling and HIV: Virologic and Biologic Consequences in the CNS

Perspective
First Online:
Received:
Accepted:

Abstract

Considerable studies have evaluated the interaction between Wnt/β-catenin signaling and numerous cellular processes. Emerging findings now demonstrate that Wnt/β-catenin signaling interacts with the life cycle of the Human Immunodeficiency Virus type 1 (HIV-1). Wnt/β-catenin is a restrictive pathway to HIV replication in multiple target cells including peripheral blood mononuclear cells and astrocytes. The molecular interaction between Wnt/β-catenin signaling and HIV has been evaluated in astrocytes because they express robust level of this pathway. The cross talk that occurs between these two components has significant biologic consequences to HIV-mediated neuropathogenesis. This perspective highlights current knowledge regarding the interaction between Wnt/β-catenin signaling and HIV, the interplay between these two pathways as it impacts key features of NeuroAIDS, and provides an assessment of knowledge gaps in the field that could propel our understanding of this interaction to inform novel strategies to exploit Wnt signaling for therapeutic intervention in HIV/NeuroAIDS.

Keywords

HIV NeuroAIDS Astrocytes Wnt signaling 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgment

I thank colleagues in the Wnt signaling field that have paved the way and discovered key tools to benefit the greater Wnt field community. I also thank present and past members of the Al-Harthi lab who propelled these studies forward (Lisa J. Henderson, Srinivasa Narasipura, Maureen Richards, Deborah Carrol-Anzinger; Anvita Kumar, and Wei Li). This work was supported by the following grants from the National Institutes of Health: R01 NS060632, R03 DA 026723, R01 DA 033966, and PO1A1082971.

Conflict of interest

The author declares no conflict of interest

References

  1. Caroll-Anzinger D, Kumar A, Adarichev V, Kashanchi F, Al-Harthi L (2007) HIV restricted replication in astrocytes and the ability of IFNg to modulate this restriction is regulated by a downstream effector of the Wnt signaling pathway. J Virol 81:5864–5871CrossRefGoogle Scholar
  2. Carvalho-Pinto CE, Garcia MI, Mellado M, Rodriguez-Frade JM, Martin-Caballero J, Flores J, Martinez AC, Balomenos D (2002) Autocrine production of IFN-gamma by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice. J Immunol 169:1058–1067PubMedGoogle Scholar
  3. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L (2009) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5:100–107PubMedCrossRefGoogle Scholar
  4. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR (2009) Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 66:253–258PubMedCrossRefGoogle Scholar
  5. Coiras M, Lopez-Huertas MR, Sanchez del Cojo M, Mateos E, Alcami J (2010) Dual role of host cell factors in HIV-1 replication: restriction and enhancement of the viral cycle. AIDS Rev 12:103–112PubMedGoogle Scholar
  6. DeCarolis NA, Wharton KA Jr, Eisch AJ (2008) Which way does the Wnt blow? Exploring the duality of canonical Wnt signaling on cellular aging. Bioessays 30:102–106PubMedCrossRefGoogle Scholar
  7. Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY, Hung MC (2002) Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2:323–334PubMedCrossRefGoogle Scholar
  8. Dinoso JB, Kim SY, Wiegand AM, Palmer SE, Gange SJ, Cranmer L, O’Shea A, Callender M, Spivak A, Brennan T, Kearney MF, Proschan MA, Mican JM, Rehm CA, Coffin JM, Mellors JW, Siliciano RF, Maldarelli F (2009) Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc Natl Acad Sci U S A 106:9403–9408PubMedCrossRefGoogle Scholar
  9. Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA (2000) Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54:927–936PubMedCrossRefGoogle Scholar
  10. Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW (2007) HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc Natl Acad Sci U S A 104:3438–3443PubMedCrossRefGoogle Scholar
  11. Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32:883–909PubMedCrossRefGoogle Scholar
  12. Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R (2009) Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 23:907–915PubMedCrossRefGoogle Scholar
  13. Hauser KF, Fitting S, Dever SM, Podhaizer EM, Knapp PE (2012) Opiate drug use and the pathophysiology of NeuroAIDS. Curr HIV Res 10:435–452PubMedCrossRefGoogle Scholar
  14. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3–16PubMedCrossRefGoogle Scholar
  15. Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185:82–91PubMedCrossRefGoogle Scholar
  16. Henderson LJ, Al-Harthi L (2011) Role of beta-catenin/TCF-4 signaling in HIV replication and pathogenesis: insights to informing novel anti-HIV molecular therapeutics. J Neuroimmune Pharmacol 6:247–259PubMedCrossRefGoogle Scholar
  17. Henderson LJ, Narasipura SD, Adarichev V, Kashanchi F, Al-Harthi L (2012a) Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, beta-catenin, and SMAR1 to repress HIV transcription. J Virol 86:9495–9503PubMedCrossRefGoogle Scholar
  18. Henderson LJ, Sharma A, Monaco-Kushner MC, Major EO, Al-Harthi L (2012b) HIV Tat through its intact core and cysteine-rich domains inhibits Wnt/beta-catenin signaling in astrocytes: Relevance to HIV neuropathogenesis. J Neurosci in pressGoogle Scholar
  19. Holman AG, Mefford ME, O’Connor N, Gabuzda D (2010) HIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites. AIDS Res Ther 7:43PubMedCrossRefGoogle Scholar
  20. Hoverter NP, Waterman ML (2008) A Wnt-fall for gene regulation: repression. Sci Signal 1:pe43PubMedCrossRefGoogle Scholar
  21. Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B (2009) Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 6:118PubMedCrossRefGoogle Scholar
  22. Kumar A, Zloza A, Moon RT, Watts J, Tenorio AR, Al-Harthi L (2008) Active {beta}-catenin signaling is an inhibitory pathway of HIV replication in peripheral blood mononuclear cells. J Virol 82:2813–2820PubMedCrossRefGoogle Scholar
  23. Li J, Liu Y, Park IW, He JJ (2002) Expression of exogenous Sam68, the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate impaired Rev function in astrocytes. J Virol 76:4526–4535PubMedCrossRefGoogle Scholar
  24. Li W, Henderson LJ, Major EO, Al-Harthi L (2011) IFN-{gamma} mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the {beta}-catenin pathway (DKK1) in a STAT 3-dependent manner. J Immunol 186:6771–6778PubMedCrossRefGoogle Scholar
  25. Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A, He JJ (2000) Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat Med 6:1380–1387PubMedCrossRefGoogle Scholar
  26. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ (2004) CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78:4120–4133PubMedCrossRefGoogle Scholar
  27. Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S (1999) HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73:578–586PubMedCrossRefGoogle Scholar
  28. Malim MH, Bieniasz PD (2012) HIV restriction factors and mechanisms of evasion. Cold Spring Harb Perspect Med 2:a006940PubMedGoogle Scholar
  29. Miyabayashi T, Teo JL, Yamamoto M, McMillan M, Nguyen C, Kahn M (2007) Wnt/beta-catenin/CBP signaling maintains long-term murine embryonic stem cell pluripotency. Proc Natl Acad Sci U S A 104:5668–5673PubMedCrossRefGoogle Scholar
  30. Munder M, Mallo M, Eichmann K, Modolell M (1998) Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med 187:2103–2108PubMedCrossRefGoogle Scholar
  31. Narasipura SD, Henderson LJ, Fu SW, Chen L, Kashanchi F, Al-Harthi L (2012) Role of beta-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol 86:1911–1921PubMedCrossRefGoogle Scholar
  32. Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Ann N Y Acad Sci 1187:122–128PubMedCrossRefGoogle Scholar
  33. Neil SJ, Zang T, Bieniasz PD (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425–430PubMedCrossRefGoogle Scholar
  34. Ong CL, Thorpe JC, Gorry PR, Bannwarth S, Jaworowski A, Howard JL, Chung S, Campbell S, Christensen HS, Clerzius G, Mouland AJ, Gatignol A, Purcell DF (2005) Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J Virol 79:12763–12772PubMedCrossRefGoogle Scholar
  35. Poli V (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273:29279–29282PubMedCrossRefGoogle Scholar
  36. Purohit V, Rapaka R, Shurtleff D (2011) Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia. Mol Neurobiol 44:102–110PubMedCrossRefGoogle Scholar
  37. Ruocco MR, Chen X, Ambrosino C, Dragonetti E, Liu W, Mallardo M, De Falco G, Palmieri C, Franzoso G, Quinto I, Venuta S, Scala G (1996) Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors. J Biol Chem 271:22479–22486PubMedCrossRefGoogle Scholar
  38. Schindler H, Lutz MB, Rollinghoff M, Bogdan C (2001) The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol 166:3075–3082PubMedGoogle Scholar
  39. Schnell G, Price RW, Swanstrom R, Spudich S (2010) Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol 84:2395–2407PubMedCrossRefGoogle Scholar
  40. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R (2011) HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog 7:e1002286PubMedCrossRefGoogle Scholar
  41. Sharma A, Hu XT, Napier TC, Al-Harthi L (2011) Methamphetamine and HIV-1 Tat down regulate beta-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity. J Neuroimmune Pharmacol 6:597–607PubMedCrossRefGoogle Scholar
  42. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646–650PubMedCrossRefGoogle Scholar
  43. Sreenath K, Pavithra L, Singh S, Sinha S, Dash PK, Siddappa NB, Ranga U, Mitra D, Chattopadhyay S (2010) Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling. Virology 400:76–85PubMedCrossRefGoogle Scholar
  44. Sui Z, Sniderhan LF, Fan S, Kazmierczak K, Reisinger E, Kovacs AD, Potash MJ, Dewhurst S, Gelbard HA, Maggirwar SB (2006) Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Eur J Neurosci 23:2623–2634PubMedCrossRefGoogle Scholar
  45. Vijaykumar TS, Nath A, Chauhan A (2008) Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection. Virology 381:1–5PubMedCrossRefGoogle Scholar
  46. Williams RS, Harwood AJ (2000) Lithium therapy and signal transduction. Trends Pharmacol Sci 21:61–64PubMedCrossRefGoogle Scholar
  47. Wortman B, Darbinian N, Sawaya BE, Khalili K, Amini S (2002) Evidence for regulation of long terminal repeat transcription by Wnt transcription factor TCF-4 in human astrocytic cells. J Virol 76:11159–11165PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Immunology and MicrobiologyRush University Medical CenterChicagoUSA

Personalised recommendations